Pharmaceutical Technology on MSN2mon
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trialWhilst vaccines exist for animals, none are commercially available for human use for the mosquito-borne virus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback